Featured Post

Latest Gold News

Klondike retracts misleading claims Sentiment for gold rising Some people will never get gold This billionaire quickly adding to gol...

Friday, December 30, 2011

Amgen (AMGN) Ratings, Price Targets

Updates on Amgen (NASDAQ: AMGN) ratings and price targets.

Bank of America (NYSE: BAC) raised their price target on Amgen (AMGN) to $65.00.

Citigroup (NYSE: C) raised their price target on Amgen to $73.00. They have a “Buy” rating on the company.

Piper Jaffray (NYSE: PJC) reiterated a “Neutral” rating on Amgen. They have a price target of $65.00 on the company.

TheStreet upgraded Amgen to a “Buy” rating.

UBS AG (NYSE: UBS) raised their price target on Amgen (AMGN) to $59.00. They have a “Neutral” rating on the company.

Barclays Capital (BCS) initiated coverage on Amgen. They placed an “Equal Weight” rating and a price target of $65.00 on the company.

No comments: